Stay updated on DAPA-MI Trial: Dapagliflozin Post Heart Attack
Sign up to get notified when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.

Latest updates to the DAPA-MI Trial: Dapagliflozin Post Heart Attack page
- Check5 days agoChange DetectedThe page now displays a new footer revision notice 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' link and the previous 'Revision: v3.3.2' text were removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry (v3.3.2) was added to the page history, and the previous revision (v3.3.1) was removed.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page shows a new Revision: v3.3.1 replacing v3.2.0, indicating a system/UI update. No study data, trial details, or core content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding/status notice banner was removed from the page in the latest version, affecting only the UI banner and not the trial records or study details.SummaryDifference0.4%

- Check55 days agoChange DetectedNew screenshot shows minor UI/layout adjustments to the Record History page; the version list and primary content appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference10%

Stay in the know with updates to DAPA-MI Trial: Dapagliflozin Post Heart Attack
Enter your email address, and we'll notify you when there's something new on the DAPA-MI Trial: Dapagliflozin Post Heart Attack page.